Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIRZEPATIDE Cause Intestinal obstruction? 361 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Intestinal obstruction have been filed in association with TIRZEPATIDE (Zepbound). This represents 0.4% of all adverse event reports for TIRZEPATIDE.

361
Reports of Intestinal obstruction with TIRZEPATIDE
0.4%
of all TIRZEPATIDE reports
5
Deaths
220
Hospitalizations

How Dangerous Is Intestinal obstruction From TIRZEPATIDE?

Of the 361 reports, 5 (1.4%) resulted in death, 220 (60.9%) required hospitalization, and 11 (3.0%) were considered life-threatening.

Is Intestinal obstruction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 361 reports have been filed with the FAERS database.

What Other Side Effects Does TIRZEPATIDE Cause?

Incorrect dose administered (23,301) Injection site pain (10,989) Nausea (10,018) Off label use (7,007) Extra dose administered (6,774) Diarrhoea (5,463) Vomiting (4,635) Injection site haemorrhage (4,389) Accidental underdose (3,897) Injection site erythema (3,844)

What Other Drugs Cause Intestinal obstruction?

ADALIMUMAB (5,727) VEDOLIZUMAB (1,263) SEMAGLUTIDE (924) INFLIXIMAB (907) RISANKIZUMAB-RZAA (853) BEVACIZUMAB (686) LENALIDOMIDE (504) CLOZAPINE (484) OCTREOTIDE (463) USTEKINUMAB (459)

Which TIRZEPATIDE Alternatives Have Lower Intestinal obstruction Risk?

TIRZEPATIDE vs TISAGENLECLEUCEL TIRZEPATIDE vs TISLELIZUMAB TIRZEPATIDE vs TISOTUMAB VEDOTIN TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC

Related Pages

TIRZEPATIDE Full Profile All Intestinal obstruction Reports All Drugs Causing Intestinal obstruction TIRZEPATIDE Demographics